congenital heart disease. Congenital malformation of heart, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Suffering from congenital heart disease Risk adjustment for congenital heart surgery score below 5 Age below or equal to 18 years Serum vitamin D level below or equal to 150 nanograms per milliliter Consent from parent or legal guardian to participate in the study The patient being candidate for open heart surgery
Exclusion criteria
Exclusion criteria: Being treated with steroidal drugs Vitamin D contraindications Application of cardio-respiratory support device Contraindications for oral medication Active cardiopulmonary resuscitation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vasoactive-Inotrope Score. Timepoint: 24 and 48 hours postoperatively. Method of measurement: Vasoactive-Inotrope Score calculation formula.;Vasoactive-Inotrope Score. Timepoint: 24 and 48 hours postoperatively. Method of measurement: Inotrope Score calculation formula. | — |
Countries
Iran (Islamic Republic of)
Contacts
Birjand University of Medical Sciences